PAVmed (PAVM) to Release Earnings on Thursday

PAVmed (NASDAQ:PAVM) is expected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, May 15th. Analysts expect PAVmed to post earnings of ($0.40) per share and revenue of $0.02 million for the quarter.

PAVmed Price Performance

Shares of PAVM stock opened at $0.72 on Wednesday. The company has a market capitalization of $12.36 million, a P/E ratio of -0.17 and a beta of 1.11. The company’s 50-day simple moving average is $0.71 and its two-hundred day simple moving average is $0.77. PAVmed has a one year low of $0.55 and a one year high of $2.35.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets increased their price objective on PAVmed from $19.00 to $19.50 and gave the stock a “buy” rating in a research note on Monday, April 21st.

About PAVmed

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.